Ukulungiselela "Phosphogliv": ukubuyekezwa nemiyalelo

I-hepatoprotector, nge-action immunomodulating eyengeziwe kanye ne-antiviral, "ukubuyekezwa kwe-Phosphogliv" ezivela ezigulini kunezingxenye eziningi ezinhle. Isizathu salesi sidakamizwa singase sibe nesifo sofuba esibangelwa yi- viral hepatitis (kokubili esingapheli futhi esicindezelayo), isifo sofuba, ukulimala okuhlukahlukene kwesibindi (ngenxa yokuhlukumeza izidakamizwa, utshwala noma izinto ezinobuthi), njll.

Naphezu kokuthi intengo yezidakamizwa "Phosphogliv" iphakeme ngokwanele, ukusebenza kwayo kuye kwafakazelwa ngokufaka isicelo ngokuphindaphindiwe futhi iziguli zishiya ngemva kwalokho. Ukusebenzisa ukwelashwa kwezidakamizwa kuyadingeka kuphela emva kweseluleko sikadokotela wephrofayli efanele. Ukukhulelwa nokukhwabanisa kuyaphikisana ngokuqokwa komuthi. Futhi, ungabeki umuthi uma kwenzeka kukhona uzwela kunoma yisiphi isici esiqukethe.

Ukulungiselela "Phosphogliv" kunokubunjwa okulandelayo. Izinto ezisebenzayo, eziqinisekisa ukusebenza kwayo, ziyi-phospholipids ne-sodium glycyrrhizinate. Isidakamizwa sitholakala ngesimo samaphilisi noma isisombululo. Esikhathini esilandelayo, singase sibe nomuthi wokusiza we-maltose.

Ukuhlolwa kwe-hepatoprotector "Phosphogliv" kubhekwa njengendlela yokwelapha ephumelelayo yokudakwa. Kube khona amacala okudlulela kwezidakamizwa ukuba afinyelele. Ama-capsules awavunyelwe izingane ezingaphansi kweminyaka engu-12 ubudala. Isidakamizwa sithwetshiwe ngokusuka kumgudu wokugaya, izingxenye zayo zisakazwa kuwo wonke umzimba, zingena esibindi, amaphaphu nezinye izitho. I-agent inomthelela we-antiviral, ikakhulukazi ngenxa ye-glycyrate, okuyingxenye yokwakhiwa kwayo. Leli qembu lisiza ukugqugquzela imikhiqizo ye-interferon, futhi yandisa umsebenzi wemvelo wamaseli aMvelo abulalayo.

Mayelana nalokhu, izidakamizwa "Phosphogliv" zibuyekezwa futhi zinezifo ezithathelwanayo, uma udokotela eqokwe. Isilinganiso nobude besikhathi sokwelashwa kunqunywa ochwepheshe owenza ukwelashwa. Imfundo evela kubakhiqizi iluleka imithi ukuthi ingaphuzi okungaphezu kwezikhathi ezine ngosuku, kuma-capsules angu-1-2. Uma ngabe izidakamizwa zenziwa ngendlela engaphakathi, isetshenziswe ekuseni nakusihlwa, ngokuvamile izinsuku ezingu-10. Isikhathi sokwelashwa sinqunywa imiphumela yokuhlaziya.

Phakathi kwemiphumela emibi ukuthi lesi sidakamizwa sinakho, kufanele kuqashelwe ukuthi kwenzeke ukuphendula okweqileko ngendlela yokubomvu, ukushona noma ukushaya. Nokho, ngokukhanselwa kwezimali, zonke izinto ezimbi zidlula ngokushesha. Ukuphendula okunjalo ngemva kokusetshenziswa kwezidakamizwa "iziguli ze-Phosphogliv" akuvamile.

Ukusebenzisana okungalungile nanoma yimiphi imithi akuzange kubonwe. Ngokuqapha, lesi sidakamizwa sisetshenziselwa iziguli ezine-hypertension. Kwakungekho amacala okudlula ngokweqile ngale mithi.
Ukusetshenziswa kwe-hepatoprotector "Phosphogliv" kuletha umphumela ophawulekayo ngezifo ezihambisanayo, njengoba kuboniswe ukubuyekezwa kweziguli nodokotela bazo. Imiphumela yokuhlolwa kwezifo ezinjenge-hepatitis, psoriasis, neurodermatitis kungcono kakhulu emva kokuthatha imithi.